UCB S.A. (UCBJF) News Nov 3, 2014, 12:00 a.m. Mar

UCB S.A. (UCBJF) News Nov 3, 2014, 12:00 a.m.
MarketWatch News on UCBJF
Immunomedics, UCB tweak pact on cancer, lupus drug 1:53 a.m. Dec. 28, 2011 - Robert Daniel
Belgium's UCB to pay $34 mln for misbranding drug 11:31 a.m. June 9, 2011 - Sue Chang
Israel stocks edge higher, lifted by energy sector 10:12 a.m. May 19, 2011 - Robert Daniel
Updates, advisories and surprises 10:01 a.m. March 2, 2010 - MarketWatch
UCB '09 net rose; core net for 2010 seen up 1.1% 1:28 a.m. March 2, 2010 - Robert Daniel
Market rises; Discount and Leumi up after Fannie-Freddie move 8:06 a.m. Sept. 8, 2008 - Robert Daniel
Thursday's biggest gaining and declining stocks 4:37 p.m. Aug. 28, 2008 - MarketWatch
UCB plans to cut 17% of work force as part of revamping 6:01 a.m. Aug. 28, 2008 - Robert Daniel
Update: UCB to cut 2,000 jobs as part of revamping 2:28 a.m. Aug. 28, 2008 - Robert Daniel
UCB restless-leg drug accepted by Europe agency for review 1:21 a.m. Dec. 5, 2007 - Robert Daniel
FDA to review UCB application to market epilepsy drug 1:29 a.m. Nov. 29, 2007 - Robert Daniel
Sanofi, UCB: FDA OKs Xyzal for allergies, chronic hives 11:17 a.m. May 29, 2007 - Katherine Hunt
Sanofi, UCB: FDA OKs Xyzal for allergies, chronic hives 11:08 a.m. May 29, 2007 - Katherine Hunt
Stocks expected to move Tuesday 6:57 p.m. Oct. 2, 2006 - MarketWatch
Biogen, UCB to develop and market CDP323 3:32 p.m. Oct. 2, 2006 - Ana Campoy
Advertisement
Other News on UCBJF
Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? - Analyst Blog 5:30 p.m. Nov. 12, 2014 - Zacks.com
UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog 5:30 p.m. Nov. 10, 2014 - Zacks.com
UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog 5:40 p.m. Sept. 17, 2014 - Zacks.com
Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog 4:20 p.m. Sept. 9, 2014 - Zacks.com
UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog 3:45 p.m. Sept. 2, 2014 - Zacks.com
UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog 3:40 p.m. Aug. 28, 2014 - Zacks.com
Drug Patent Expirations This Week: UCB, Roche's Genentech 8:17 a.m. Aug. 8, 2014 - Seeking Alpha
Drug Patent Expirations This Week: UCB, Inc., Roche's Genentech 8:17 a.m. Aug. 8, 2014 - Seeking Alpha
UCB's (UCBJF) CEO Roch Doliveux on Q2 2014 Results - Earnings Call Transcript 12:11 p.m. July 30, 2014 - Seeking Alpha
9 Health Care Stocks From Index-Crushing Fund 6:45 p.m. July 25, 2014 - Barrons.com
UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog 4:40 p.m. July 24, 2014 - Zacks.com
UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog 5:10 p.m. July 7, 2014 - Zacks.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 10:50 a.m. June 30, 2014 - Zacks.com
Sanofi Misses on Q1 Earnings, Lackluster Revs - Analyst Blog 10:07 a.m. April 30, 2014 - Zacks.com
UCB Sales Rise in Q1 - Analyst Blog 3:30 p.m. April 24, 2014 - Zacks.com
Regulatory Update from Impax - Analyst Blog 3:55 p.m. April 15, 2014 - Zacks.com
Update on Pfizer's OTC Nexium 24HR - Analyst Blog 3:30 p.m. April 1, 2014 - Zacks.com
Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog 10:00 a.m. March 27, 2014 - Zacks.com
UCB to Return Tozadenant Rights - Analyst Blog 4:44 p.m. March 26, 2014 - Zacks.com
Sanofi, UCB Ink Deal - Analyst Blog 5:10 p.m. March 12, 2014 - Zacks.com
Loading more headlines...
Press Releases on UCBJF
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 10:59 a.m. May 21, 2014 - PR Newswire - PRF
UCB : CONVENING NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS 3:01 a.m. Feb. 21, 2014 - Thomson Reuters ONE